Gilead Sciences notched "fine" sales for the first quarter but the biopharma promised more to come.
READ MOREFollowing a recent move to ask Congress to eliminate the interchangeability designation for biosimilars, the FDA on Wednesday proposed updated guidance on the labeling and ...
READ MOREThe FDA's Center for Biologics Evaluation and Research is planning to release some crucial guidance soon for CRISPR and gene therapy developers on platform technologies, accelerated ...
READ MOREMerck KGaA is allocating over €300 million ($321.8 million) to build a new research building at its headquarters in Darmstadt, Germany to study technologies for its life science business.
READ MORE